Based on the Entheon Biomedical Corp stock forecast from 0 analysts, the average analyst target price for Entheon Biomedical Corp is not available over the next 12 months. Entheon Biomedical Corp’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Entheon Biomedical Corp is Very Bearish, which is based on 0 positive signals and 6 negative signals. At the last closing, Entheon Biomedical Corp’s stock price was CAD 0.17. Entheon Biomedical Corp’s stock price has changed by +0.00% over the past week, +30.77% over the past month and +70.00% over the last year.
No recent analyst target price found for Entheon Biomedical Corp
No recent average analyst rating found for Entheon Biomedical Corp
Company Overview Entheon Biomedical Corp
Entheon Biomedical Corp. operates as a biotechnology research and development company. It engages in developing of products for treating addiction and substance use disorders. The company is headquartered in Vancouver, Canada. Address: 999 West Broadway, Vancouver, BC, Canada, V5Z 1K5 Read Less
Entheon Biomedical Corp. operates as a biotechnology research and development company. It engages in developing of products for treating addiction and substance use disorders. The company is headquartered in Vancouver, Canada. Address: 999 West Broadway, Vancouver, BC, Canada, V5...Read More
N/A
N/A
1
N/A
CAD
Canada
Adjusted Closing Price for Entheon Biomedical Corp (ENBI:CA)
Loading...
Unadjusted Closing Price for Entheon Biomedical Corp (ENBI:CA)
Loading...
Share Trading Volume for Entheon Biomedical Corp Shares
Loading...
Compare Performance of Entheon Biomedical Corp Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for ENBI:CA
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To Entheon Biomedical Corp (Sector: Biotechnology )
Frequently Asked Questions About Entheon Biomedical Corp (ENBI:CA) Stock
Stock Target Advisor's fundamental analysis for Entheon Biomedical Corp's stock is Very Bearish.
Unfortunately we do not have enough data on ENBI:CA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ENBI:CA's stock to indicate what its average analyst target is.
ENBI:CA stock's Price/Earning ratio is 0.81.
Our analysis grades ENBI:CA stock's Price / Earning ratio at F. This means that ENBI:CA stock's Price/Earning ratio is above 43.99999999999999% of the stocks in the Biotechnology sector in the CNSX exchange.
Based on this ENBI:CA may be fairly valued for its sector
The last closing price of ENBI:CA's stock was CAD 0.17.
The most recent market capitalization for ENBI:CA is CAD 1.24M.
Unfortunately we do not have enough analyst data on ENBI:CA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Entheon Biomedical Corp's stock.
As per our most recent records Entheon Biomedical Corp has 1 Employees.
Sorry we do not have any infomation available on Entheon Biomedical Corp's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Entheon Biomedical Corp (ENBI:CA) Stock
Stock Target Advisor's fundamental analysis for Entheon Biomedical Corp's stock is Very Bearish.
Unfortunately we do not have enough data on ENBI:CA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ENBI:CA's stock to indicate what its average analyst target is.
ENBI:CA stock's Price/Earning ratio is 0.81.
Our analysis grades ENBI:CA stock's Price / Earning ratio at F. This means that ENBI:CA stock's Price/Earning ratio is above 43.99999999999999% of the stocks in the Biotechnology sector in the CNSX exchange.
Based on this ENBI:CA may be fairly valued for its sector
The last closing price of ENBI:CA's stock was CAD 0.17.
The most recent market capitalization for ENBI:CA is CAD 1.24M.
Unfortunately we do not have enough analyst data on ENBI:CA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Entheon Biomedical Corp's stock.
As per our most recent records Entheon Biomedical Corp has 1 Employees.
Sorry we do not have any infomation available on Entheon Biomedical Corp's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ENBI:CA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
